← FDA DRUG APPROVALS

FDA ANDA · ANDA078148

ZOLPIDEM TARTRATE

Sponsor: PH HEALTH

APPLICATION
ANDA078148
TYPE
ANDA
ORIGINAL APPROVAL
2010-12-03
LATEST ACTION
2019-11-19
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ZOLPIDEM TARTRATEDiscontinued
ZOLPIDEM TARTRATE 6.25MG · TABLET, EXTENDED RELEASE · ORAL
ZOLPIDEM TARTRATEDiscontinued
ZOLPIDEM TARTRATE 12.5MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2019-11-19Labeling · Supplement 15 · standardAP
2019-11-19Labeling · Supplement 13 · standardAP
2019-11-19Labeling · Supplement 11 · standardAP
2019-11-19Labeling · Supplement 12 · standardAP
2015-03-19Labeling · Supplement 9 · standardAP
2014-04-01Labeling · Supplement 7 · standardAP
2010-12-03OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →